Skip to content

Innovating a Questionnaire to Investigate the Awareness of Dermatologists Regarding the Role of Physical Therapy

Innovating a Questionnaire to Investigate the Awareness of Dermatologists Regarding the Role of Physical Therapy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06986473
Enrollment
165
Registered
2025-05-23
Start date
2024-09-18
Completion date
2025-04-24
Last updated
2025-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Measure the Level of Awareness of Dermatologists

Keywords

physical therapy, dermatologists, skin diseases, referral practices, interprofessional collaboration, awareness, Egypt, Questionnaire

Brief summary

The purpose of this study will be developing a questionnaire to evaluate the level of awareness of dermatologists regarding the role of physical therapy in patients with different skin diseases. BACKGROUND: Skin diseases encompass a wide range of conditions that affect the skin, hair, and nails. They can be acute or chronic, benign or malignant, and can significantly impact an individual's quality of life. Understanding the epidemiology, causes, types, prevalence, and treatment options of skin diseases is crucial for effective management and improving patient outcomes, especially in regions like the Middle East and Egypt. The treatment of skin diseases in the Middle East and Egypt involves a combination of topical and systemic therapies, lifestyle modifications, and sometimes surgical interventions. While treatments can be effective, they may also have side effects Physical therapy plays a significant and often underappreciated role in the management of various skin diseases. While traditionally associated with musculoskeletal and neurological conditions, it can also be beneficial in treating and managing skin-related disorders

Interventions

OTHERQuestionnaire that measure the level of awareness of dermatologists

This study will be an observational cross-sectional analytical study that will recruit 165 dermatologists of both genders according to sample size calculation from different outpatient clinics in Cairo teaching hospitals. The aim of the study will be to develope a questionnaire to evaluate the awareness of Egyptian dermatologist towards the role of physical therapy in patients with various skin diseases

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
24 Years to No maximum

Inclusion criteria

* Dermatologists that will be included in the study will be with; 1. Professional Status: Must be a certified dermatologist. 2. Location: Must be practicing in Cairo teaching hospitals. 3. Active Practice: Must currently be practicing either in a clinical setting, hospital, or private practice. 4. Consent: Must provide informed consent to participate in the study. 5. Experience: Dermatologists of more than 5 years of experience.

Exclusion criteria

* This study will exclude dermatologists with the following criteria; 1. Non-Dermatologists: Professionals who are not dermatologists, such as general practitioners, nurses, or other healthcare providers who do not specialize in dermatology. 2. Inactive Professionals: Dermatologists who are retired or currently not practicing for any reason (e.g., on extended leave). 3. Non-Consenting Individuals: Individuals who do not agree to participate in the study or who do not provide informed consent. 4. Incomplete Surveys: Participants who do not complete the entire survey or interview process, depending on the data collection method used in the study. 5. Non-Egyptian Practitioners: Dermatologists practicing outside of Egypt, even if they are Egyptian nationals, to maintain a focus on the practices and awareness within the Egyptian healthcare system

Design outcomes

Primary

MeasureTime frame
Level of awareness of Egyptian dermatologists4 months

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026